Search
| Books | New Products | Special Issues | Sample Articles | For Authors | Supplier Info
 
 
 

 

Article Abstracts

Published:Journal of Chromatographic Science, ISSN 0021-9665Volume 41, Number 7, August 2003, pp. 371-376

A Validated HPLC Method for the Assay of Xanthone and 3-Methoxyxanthone in PLGA Nanocapsules

Maribel Teixeira[1],[2], Carlos M.M. Afonso[1], Madalena M.M.M. Pinto[1], and Carlos Maurício Barbosa[3],[4]
[1]Centro de Estudos de Química Orgânica, Fitoquímica e Farmacologia da Universidade do Porto-Faculdade de Farmácia do Porto, R. Aníbal Cunha, 164, 4050 Porto, Portugal;
[2]Instituto Superior de Ciências da Saúde-Norte, R. Central de Gandra, 1317, 4580 Paredes, Portugal;
[3]CTMUP/ Faculdade de Farmácia do Porto, R. Aníbal Cunha, 164, 4050 Porto, Portugal;
[4]CETMED-Centro Tecnológico do Medicamento, R. do Passeio Alegre, 840, 4150- 574 Porto, Portugal

This work relates the development and validation of a simple reversed-phase high-performance liquid chromatographic (HPLC) method for the analysis of xanthone (XAN) and 3-methoxyxanthone (3-MeOXAN) in poly(d,l-lactide-co-glycolide) (PLGA) nanocapsule formulations. This method does not require any complex sample extraction procedure. Chromatographic separation is made with a reversed-phase C18 column, using methanol–water (90:10, v/v) as a mobile phase at a flow rate of 1 mL/min. Identification is made by UV detection at 237 nm. The isocratic system operates at ambient temperature and requires 7 min of chromatographic time. The developed method is statistically validated according to United States Pharmacopoeia 25 and International Conference on Harmonization guidelines for its specificity, linearity, accuracy, and precision. The assay method proposed in this study is specific for XAN and 3-MeOXAN in the presence of nanocapsule excipients. Diode-array analyses confirm the homogeneity of XAN and 3-MeOXAN peaks in stressed conditions. Standard curves are linear (r > 0.999) over the concentration range of 0.4–2.5 and 1.0–5.8 µg/mL for XAN and 3-MeOXAN, respectively. Recovery from nanocapsules ranges from 99.6% to 102.8% for XAN and 98.8% to 102.4% for 3-MeOXAN. Repeatability (intra-assay precision) is acceptable with relative standard deviation values of 1.2% for XAN and 0.3% for 3-MeOXAN.

Reproduction of editorial content of this journal is prohibited without publisher’s permission.

This article is available in its entirety by fax for $4.00 per page.
Visa or MasterCard accepted.

To order electronically click here
or call: 847-647-2900 ext. 1323
or fax request to: 847-647-1155.

Please indicate JCS volume and issue along with page numbers.

Site Map: Home | Current Issue | Subscribe | Back Issues | About Us | Meetings | Advertising |
| Books for Sale | For the Author | Links | Supplier Info | Search |